CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2047-9158
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers ; volume:9 ; number:1 ; day:6 ; month:5 ; year:2020 ; pages:1-10 ; date:12.2020
Translational neurodegeneration ; 9, Heft 1 (6.5.2020), 1-10, 12.2020

Creator
Majbour, Nour K.
Aasly, Jan O.
Hustad, Eldbjørg
Thomas, Mercy A.
Vaikath, Nishant N.
Elkum, Naser
Berg, Wilma D. J. van de
Tokuda, Takahiko
Mollenhauer, Brit
Berendse, Henk W.
El-Agnaf, Omar M. A.
Contributor
SpringerLink (Online service)

DOI
10.1186/s40035-020-00192-4
URN
urn:nbn:de:101:1-2020071323234915361620
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:46 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Majbour, Nour K.
  • Aasly, Jan O.
  • Hustad, Eldbjørg
  • Thomas, Mercy A.
  • Vaikath, Nishant N.
  • Elkum, Naser
  • Berg, Wilma D. J. van de
  • Tokuda, Takahiko
  • Mollenhauer, Brit
  • Berendse, Henk W.
  • El-Agnaf, Omar M. A.
  • SpringerLink (Online service)

Other Objects (12)

LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models

LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models

Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells

Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells

NME1 Protects Against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson’s Disease

NME1 Protects Against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson’s Disease

LRRK2 contributes to monocyte dysregulation in Parkinson’s disease

LRRK2 contributes to monocyte dysregulation in Parkinson’s disease

LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?

LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?

Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions

Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions

Mitochondria-targeted oligomeric α-synuclein induces TOM40 degradation and mitochondrial dysfunction in Parkinson’s disease and parkinsonism-dementia of Guam

Mitochondria-targeted oligomeric α-synuclein induces TOM40 degradation and mitochondrial dysfunction in Parkinson’s disease and parkinsonism-dementia of Guam

Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition

Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition

Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons

Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons

Models of α-synuclein aggregation in Parkinson’s disease

Models of α-synuclein aggregation in Parkinson’s disease

Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules

Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules

Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance

Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance

Related objects